REDWOOD SHORES, Calif., Dec. 09, 2015 (GLOBE NEWSWIRE) -- Imperva, Inc., (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced that Mark Kraynak has been appointed the company’s Senior Vice President and General Manager of the Enterprise Solutions group. Mark will continue to report directly to President and CEO, Anthony Bettencourt, and has global responsibility for growing the company’s enterprise business, which includes the Imperva SecureSphere and Imperva CounterBreach product lines.
A 12-year Imperva veteran and well-recognized leader in the cyber security industry, Mark was formerly Chief Product Officer at Imperva, responsible for product strategy, business development, corporate development, and evangelism. During his tenure at Imperva, he has played instrumental roles in the company’s growth and success, serving in a variety of product- and marketing-related roles, as well as being a board director for Incapsula, prior to the Imperva acquisition in 2014.
Prior to Imperva, Mark led product marketing at Check Point Software Technologies Ltd., and held a position in marketing at CacheFlow, now BlueCoat Systems. Earlier in his career, he provided technology architecture consulting for Fortune 500 clients with Ernst & Young's Center for Technology Enablement. Mark holds a BSC in Electrical Engineering and English from Duke University, and an MFA in Literature from American University.
“Mark has a proven track record at Imperva for delivering product innovation year after year,” said Anthony Bettencourt. “Mark’s vision and leadership skills are well suited to lead the company’s Enterprise Solutions group as we continue to grow this critical portion of our business.”
“Imperva is in a unique position in the market, with security professionals recognizing the need to secure not just end points and networks, but more importantly, business critical data repositories and the applications that access them,” said Mark Kraynak. “Even after 12 years, I remain excited about the company’s potential and look forward to contributing to the next phase of our growth.”
About Imperva
Imperva® (NYSE:IMPV), is a leading provider of cyber security solutions that protect business-critical data and applications. The company’s SecureSphere, CounterBreach, Incapsula and Skyfence product lines enable organizations to discover assets and risks, protect information wherever it lives – in the cloud and on-premises – and comply with regulations. The Imperva Application Defense Center, a research team comprised of some of the world’s leading experts in data and application security, continually enhances Imperva products with up-to-the-minute threat intelligence, and publishes reports that provide insight and guidance on the latest threats and how to mitigate them. Imperva is headquartered in Redwood Shores, California. Learn more: www.imperva.com, our blog, on Twitter.
© 2015 Imperva, Inc. All rights reserved. Imperva, the Imperva logo, SecureSphere, CounterBreach, Incapsula and Skyfence are trademarks of Imperva, Inc. and its subsidiaries.
EDITORIAL CONTACTS: Winifred Shum Imperva [email protected] Edelman [email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Apple Turns 50: From Garage Startup to AI Crossroads
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



